- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostate Cancer Adenocarcinoma
Total 57921 results
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Hormone-Resistant Prostate CancerCanada
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)RecruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
The Methodist Hospital Research InstituteRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLCRecruitingCastration-resistant Prostate CancerUnited Kingdom
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaRecruiting
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedStage IV Prostate CancerUnited States
-
Stanford UniversityWithdrawnProstate Cancer | Castrate Resistant Prostate Cancer
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
Won KimNovartisTerminated
-
Terence Friedlander, MDJanssen Biotech, Inc.CompletedCastration Resistant Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownProstate Cancer | Castration-resistant Prostate CancerChina
-
Hellenic Cooperative Oncology GroupSanofiCompletedBone Metastatic Prostate CancerGreece
-
Sunnybrook Health Sciences CentreProstate Cancer CanadaUnknownHIGH RISK PROSTATE CANCERCanada
-
Shanghai General Hospital, Shanghai Jiao Tong University...UnknownCastration-resistant Prostate Cancer
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
Sunnybrook Health Sciences CentreSunnybrook Research InstituteUnknownCastrate Resistance Prostate Cancer
-
Hoffmann-La RocheCompleted
-
Spanish Oncology Genito-Urinary GroupAstellas Pharma Inc; Apices Soluciones S.L.CompletedHormone-refractory Prostate CancerSpain
-
Peking UniversityWithdrawnHormone Refractory Prostate CancerChina
-
Exact ImagingCompletedProstatic Neoplasms | Prostate Cancer | Cancer of the ProstateCanada, United States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnStage III Prostate Cancer
-
Consorzio OncotechUnknownProstate Cancer | Castration-resistant Prostate CancerItaly
-
Prostate Oncology Specialists, Inc.CompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
Tianjin Medical University Cancer Institute and...Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaboratorsUnknownStage III Prostate CancerChina
-
AHS Cancer Control AlbertaUnknownHigh-risk Prostate CancerCanada
-
Sergio FariaCompletedHigh Risk Prostate CancerCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Johns Hopkins UniversityCompletedSuspected Primary Prostate CancerUnited States
-
Tianjin Medical University Cancer Institute and...UnknownHormone Refractory Prostate CancerChina
-
CytoVac A/SCompletedHormone-refractory Prostate CancerDenmark
-
British Columbia Cancer AgencyCompletedHormone Refractory Prostate CancerCanada
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States
-
Poniard PharmaceuticalsUnknownHormone Refractory Prostate CancerRussian Federation
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
Praful Ravi, MB BCHir, MRCPEli Lilly and Company; BayerActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Non-metastatic Prostate CancerUnited States
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
Jonsson Comprehensive Cancer CenterTerminatedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
José Joaquín MiraRecruitingProstate Cancer | Prostate Cancer DiagnosisSpain
-
Gulhane Training and Research HospitalRecruitingProstate Cancer | Prostate Cancer StageTurkey
-
Shanghai Proton and Heavy Ion CenterRecruitingLocalized Prostate CancerChina
-
West China HospitalNot yet recruitingProstate Cancer Metastatic
-
Sun Yat-sen UniversityRecruitingProstate Cancer MetastaticChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Spanish Oncology Genito-Urinary GroupAstraZeneca; Apices Soluciones S.L.CompletedProstate Cancer MetastaticSpain
-
University of FloridaCompleted
-
University of HawaiiGenentech, Inc.; DendreonCompletedProstate Cancer MetastaticUnited States
-
National Cancer Institute, EgyptCompletedProstate Cancer MetastaticEgypt
-
University of Alabama at BirminghamSanofi; Astellas Pharma IncWithdrawn